InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Durso Jerome Benedict, Chief Executive Officer. Insider active across 1 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 8 filings have been logged. The latest transaction was filed on 27 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
035,700 shares0
Common Stock
SEC:0001104659-22-009555·
035,700 shares0
Common Stock
SEC:0001104659-22-009555:0·
€80,6515,607 shares@ €14.384190.2% of flow
Common Stock
SEC:0001104659-22-000917·
€80,6515,607 shares@ €14.384145.1% of flow
Common Stock
SEC:0001104659-22-000917:0·
€3,800289 shares@ €13.14964.2% of flow
Common Stock
SEC:0001104659-21-123209·
€3,800289 shares@ €13.14962.1% of flow
Common Stock
SEC:0001104659-21-123209:0·
€4,994289 shares@ €17.27985.6% of flow
Common Stock
SEC:0001104659-21-089031·
€4,994289 shares@ €17.27982.8% of flow
Common Stock
SEC:0001104659-21-089031:0·
8 of 8 declarations
About Durso Jerome Benedict
Jerome Benedict Durso is the President and Chief Executive Officer of Intercept Pharmaceuticals, Inc. He leads the company's strategic efforts and oversees its operations. Durso is recognized for his expertise in the pharmaceutical field and his commitment to innovation and the development of new treatments.
